Premium
Is vacuum‐assisted closure therapy feasible for children with deep sternal wound infection after cardiac surgery? The pooling results from current literature
Author(s) -
Wu Yuhao,
Wang Junke,
Dai Jiangtao,
Wang Gang,
Li Hongbo,
Li Yonggang,
Wu Chun,
Wei Guanghui
Publication year - 2021
Publication title -
artificial organs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 76
eISSN - 1525-1594
pISSN - 0160-564X
DOI - 10.1111/aor.13936
Subject(s) - medicine , mediastinitis , surgery , cardiac surgery , cochrane library , negative pressure wound therapy , incidence (geometry) , randomized controlled trial , physics , alternative medicine , pathology , optics
Vacuum‐assisted closure (VAC) has been used for children with deep sternal wound infections (DSWI); however, the safety and efficiency have not been determined. A meta‐analysis was performed for outcomes of VAC therapy in children with DSWI after cardiac surgery. Electronic databases, including PubMed, Scopus, and Cochrane Library CENTRAL were searched systematically from January 1990 to October 2020 for the literature which reported the outcomes of VAC therapy for children with DSWI after cardiac surgery. Meta‐regression and subgroup analyses were performed to find risk factors for prolonged length of VAC therapy and hospital stay. Eleven studies were included in this study, involving 217 subjects. VAC therapy was performed due to mediastinitis after congenital heart diseases (CHD) repair. In children with DSWI after cardiac surgery, length of VAC therapy, and hospital stay were 11.1 days (95% CI, 9.6‐12.5 days) and 29.8 days (95% CI, 22.8‐36.9 days), respectively. Incidence of infectious and wound‐related complications was 8.5% (95% CI, 4.1%‐13.0%). Overall mortality in this setting was 5.8% (95% CI, 2.5%‐9.1%). In conclusion, in children with DSWI after cardiac surgery, length of VAC therapy and hospital stay were 11.1 and 29.8 days, respectively. Overall mortality was 5.8%. Although not significant, delayed chest closure, complex CHD, and Gram‐negative bacilli/fungal infections may potentially contribute to prolonged duration of VAC treatment.